Receive funding for your R&D Projects!
Your partner for subsidy advice
Your partner for subsidy advice
The European eel, a fish of high cultural, commercial and conservation concern, has suffered a dramatic decline over recent decades, with the number of…
The research centers on the curious shape of seahorse tails and was led by Clemson University's Michael M. Porter, an assistant professor of mechanical…
The study was jointly conducted by scientists from The Czech Academy of Sciences of the Czech Republic (AV ČR) and the Helmholtz Centre for Environmental…
Open clusters like NGC 2367 are a common sight in spiral galaxies like the Milky Way, and tend to form in their host's outer regions. On their travels about…
Novel peptidomimetic furin inhibitors strongly inhibit the furin-dependent activation of several viral surface proteins and bacte-rial toxins. Therefore, these inhibitors are a promising new approach for the treatment of diseases, which are caused by furin-dependent infectious agents.
Such diseases are for example influenza, measles, mumps, yellow fever, canine distemper, anthrax, and diphtheria.
The new chimeric nucleases exhibit an increased preference and specificity for DNA cleavage sites composed of two or three recognition sites and allow single cuts in the genome which reduces the toxic side effects substantially.
The high specificity and preference of the new chimeric nucleases is based on a fusion of TALE proteins as DNA binding modules with a highly specific restriction endonuclease, PvuII, as DNA cleavage module.